Showing results (1-10 of 3,844) with videos related to
Sort By:
Pageof 385
Journal of Hematotherapy|January 1, 1993
Processing forms used in the bone marrow transplantation laboratory: toward standardizationW H Dodge, S Sharma, B E Dunlevy, et al.Archives of Pathology & Laboratory Medicine|March 1, 1986
Red blood cell antibody identification and confirmation using commercial panels. A computer program for the IBM personal computerR T Sterling, M L O'Connor, M B Hopkins, et al.Journal of Cellular Physiology|May 1, 1985
Serum-free conditions for the growth of avian granulocyte and monocyte clones and primary leukemic cells induced by AMV, and the apparent conversion of granulocytic progenitors into monocytic cells by a factor in chicken serumW H Dodge, S SharmaPostgraduate Medicine|May 1, 1983
The chronic leukemias. Clinical picture, diagnosis, and managementD D HurdSeminars in Oncology|December 1, 1987
Allogeneic and autologous bone marrow transplantation for acute nonlymphocytic leukemiaD D HurdLeukemia Research|January 1, 1985
Avian monocytic leukemia cells release fibroblast growth factor: implications to associated myelofibrosisW H DodgeThe Review of Scientific Instruments|May 3, 2014
A spatially resolved retarding field energy analyzer design suitable for uniformity analysis across the surface of a semiconductor waferS Sharma, D Gahan, S Kechkar, et al.Genetics|November 1, 1996
Kinesin mutations cause motor neuron disease phenotypes by disrupting fast axonal transport in DrosophilaD D Hurd, W M SaxtonBone Marrow Transplantation|September 6, 2006
Autologous transplantation in elderly patients with multiple myeloma: are we asking the right questions?H D Klepin, D D HurdJournal of the National Cancer Institute. Monographs|January 1, 1995
Randomized, comparative study of high-dose (with autologous bone marrow support) versus low-dose cyclophosphamide, cisplatin, and carmustine as consolidation to adjuvant cyclophosphamide, doxorubicin, and fluorouracil for patients with operable stage II or III breast cancer involving 10 or more axillary lymph nodes (CALGB Protocol 9082). Cancer and Leukemia Group BD D Hurd, W P PetersPageof 385